Publications – KalVista Pharmaceuticals

Showing 1-10 out of 19

Delayed On-demand Treatment of Hereditary Angioedema Attacks: Patient Perceptions and Associated Barriers

Savic S, El-Shanawany T, Gurugama P, Jain R, Danese S, Ulloa J, Desai V, Audhya PK, Yong P

Anxiety Associated with On-Demand Treatment for Hereditary Angioedema (HAE) Attacks

El-Shanawany T, Yong P, El-Shanawany T, Gurugama P, Jain R, Danese S, Ulloa J, Desai V, Audhya PK, Savic S

Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks

Tachdjian R, Savic S, Fridman M, Frade JP, Fasehun M, Audhya PK

Understanding Why Hereditary Angioedema Patients Often Do Not Carry Their On-Demand Treatment with Them

Geng B, van Kooten S, Heckmann M, Danese S, Goga L, Radojicic C

Anxiety Associated with On-Demand Treatment of HAE Attacks May Result in Suboptimal Attack Management

Manning M, van Kooten S, Heckmann M, Danese S, Goga L, Ogbogu PU

In Their Own Words – Patient Descriptions of the Earliest Recognition of HAE Attack Onset

Manning ME, Burnette AF, van Kooten S, Heckmann M, Danese S, Goga L, Guilarte M

Recognizing the Importance of Early On-Demand Treatment in the HAE Attack Journey

Jones DH, Ogbogu P, van Kooten S, Heckmann M, Danese S, Goga L, Magerl M

Preferences of People with Hereditary Angioedema for On-Demand Treatment: A US-Based Qualitative Study

Bukstein DA, Vibha Desai V, Goga L, Czado S, Brown M, Myers K, Audhya PK, Settipane RA, Busse PJ

Understanding the complex decision-making associated with on-demand treatment of hereditary angioedema (HAE) attacks

Grumach A, van Kooten S, Heckmann M, Danese S, Goga L, Garcez T

Remaining burden of hereditary angioedema (HAE) attacks despite modern long-term prophylaxis

Betschel S, van Kooten S, Heckmann M, Danese S, Caballero T

About